Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 3, 2008, Pages 661-666

  Zhu, Jianhua ^a,b   Qiu, Yuangang ^a,b   Wang, Qiqi ^a,b   Zhu, Yujuan ^a,b   Hu, Shenjiang ^a,b   Zheng, Liangrong ^a,b   Wang, Lihong ^a,b   Zhang, Yun ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Hemodynamics; Ischemia; Myocardial stunning; Reperfusion

Indexed keywords

CYCLOPHOSPHAMIDE; POLYETHYLENE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PERFORMANCE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HISTOPATHOLOGY; LEUKOCYTE AGGREGATION; LOW DRUG DOSE; MALE; NONHUMAN; OPEN HEART SURGERY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SHAM PROCEDURE; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL INFILTRATION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT;

EID: 49249105299     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.05.035     Document Type: Article

References (25)

1. Hearse D.J., Humphrey S.M., Nayler W.G., Slade A., and Border D. Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol 7 (1975) 315-324
2. Entman M.L., Michael L.H., Rossen R.D., Dreyer W.J., Anderson D.C., Taylor A.A., and Smith C.W. Inflammation in the course of early myocardial ischemia. FASEB J 5 (1991) 2529-2537
3. Leprán I., Koltai M., and Szekeres L. Effect of cyclophosphamide on the acute phase of experimental myocardial infarction in rats. Acta Physiol Acad Sci Hung 58 4 (1981) 311-315
4. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Goodman A.G. (Eds). Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 9th ed. 1996 (1938), McGraw-Hill, New York
5. Yang Z., Zingarelli B., and Szabó C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101 9 (2000) 1019-1026
6. Wakeno M., Minamino T., Seguchi O., Okazaki H., Tsukamoto O., Okada K., Hirata A., Fujita M., Asanuma H., Kim J., Komamura K., Takashima S., Mochizuki N., and Kitakaze M. Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation 114 18 (2006) 1923-1932
7. Hoffmeyer M.R., Scalia R., Ross C.R., Jones S.P., and Lefer D.J. PR-39, a potent neutrophil inhibitor attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 279 6 (2000) H2824-H2828
8. Zingarelli B., Salzman A.L., and Szabó C. Genetic disruption of poly (ADP-Ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83 1 (1998) 85-94
9. Jakob V.-J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61 3 (2004) 481-497
10. Shandeyla S.M.L., Kuppusamy P., Weisfeldt M.L., and Zweier J.L. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Circulation 87 (1993) 536-546
11. Miñano F.J., Tavares E., and Maldonado R. Role of macrophage inflammatory protein 2 (MIP-2) in regulating fever induced by bacterial endotoxin in normal and immunosuppressed rats. Clin Exp Pharmacol Physiol 31 10 (2004) 723-731
12. Werns S.W., Shea M.J., and Lucchesi B.R. Free radicals in ischemic myocardial injury. Free Radic Biol Med 1 (1985) 103-110
13. Zimmerman B.J., and Granger D.N. Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 59 (1990) H390-H394
14. Parker C.W. Lipid mediators produced through the lipoxygenase pathways. Annu Rev Immunol 5 (1987) 65-84
15. Pislaru S.V., Barrios L., Stassen T., Jun L., Pislaru C., and Van de Werf F. Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion effects of lytic state and occlusion time. Circulation 96 2 (1997) 659-666
16. Jennings R.B., and Reimer K.A. Factors involved in salvaging ischemic myocardium: effects of reperfusion of arterial blood. Circulation 68 Suppl. I (1983) I-25-I-36
17. Bolli R., and Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 2 (1999) 609-634
18. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222 (1984) 649
19. Kraemer R., and Mullane K.M. Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit. J Pharmacol Exp Ther 251 2 (1989) 620-626
20. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., Rottem M., and Fauci A.S. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116 (1992) 488-498
21. Plotz P.H., Klippel J.H., Decker J.L., Grauman D., Wolff B., Brown B.C., and Rutt G. Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. Ann Intern Med 91 (1979) 221-223
22. Fairley K.F., Barrie J.U., and Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet 1 (1972) 568-569
23. Austin H.A., Klippel J.H., and Balow J.E. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314 (1986) 614-618
24. Itescu S., Burke E., Lietz K., John R., Mancini D., Michler R., Rose E., Oz M., and Edwards N. Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients. Circulation 105 (2002) 1214-1219
25. Fraiser L.H., Kanekal S., and Kehrer J.P. Cyclophosphamide toxicity. Characterizing and avoiding the problem. Drugs 42 5 (1991) 781-795